Assenagon Asset Management S.A. lifted its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 5.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,285 shares of the company’s stock after purchasing an additional 2,108 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Avantor were worth $621,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of AVTR. Smartleaf Asset Management LLC increased its stake in shares of Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after purchasing an additional 830 shares during the last quarter. Global Retirement Partners LLC increased its stake in shares of Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after purchasing an additional 1,067 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Avantor by 121.6% during the 1st quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock worth $61,000 after purchasing an additional 2,056 shares during the last quarter. AlphaQuest LLC acquired a new position in shares of Avantor during the 4th quarter worth $65,000. Finally, Signaturefd LLC increased its stake in shares of Avantor by 24.9% during the 4th quarter. Signaturefd LLC now owns 4,566 shares of the company’s stock worth $96,000 after purchasing an additional 911 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.
Insider Activity at Avantor
In related news, Director Gregory L. Summe purchased 30,000 shares of the firm’s stock in a transaction dated Friday, May 23rd. The shares were acquired at an average cost of $12.50 per share, with a total value of $375,000.00. Following the completion of the purchase, the director now directly owns 100,000 shares of the company’s stock, valued at $1,250,000. This trade represents a 42.86% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph R. Massaro purchased 8,100 shares of the firm’s stock in a transaction dated Tuesday, April 29th. The shares were bought at an average cost of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the purchase, the director now directly owns 35,038 shares of the company’s stock, valued at $430,967.40. The trade was a 30.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 83,100 shares of company stock valued at $1,027,630 over the last quarter. 1.20% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on Avantor
Avantor Stock Performance
NYSE AVTR opened at $13.31 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.12 and a quick ratio of 0.75. The firm has a market capitalization of $9.07 billion, a price-to-earnings ratio of 12.80, a P/E/G ratio of 1.32 and a beta of 1.04. The company’s fifty day moving average is $13.46 and its two-hundred day moving average is $17.29. Avantor, Inc. has a 52-week low of $11.82 and a 52-week high of $28.00.
Avantor (NYSE:AVTR – Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.61 billion. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The firm’s revenue was down 5.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.22 EPS. Equities research analysts forecast that Avantor, Inc. will post 1.06 EPS for the current year.
Avantor Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
See Also
- Five stocks we like better than Avantor
- Election Stocks: How Elections Affect the Stock Market
- Chime’s Smart IPO: Half the Valuation, Double the Strength
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks
- Best Stocks Under $10.00
- 3 Catalysts in 7 Days: Archer’s Growth Story Just Accelerated
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.